Ultrasensitive NGS MRD assessment in Ph+ ALL: Prognostic impact and correlation with RT-PCR for BCR::ABL1.

Short, Nicholas J; Jabbour, Elias; Macaron, Walid; Ravandi, Farhad; Jain, Nitin; Kanagal-Shamanna, Rashmi; Patel, Keyur P; Loghavi, Sanam; Haddad, Fadi G; Yilmaz, Musa; Issa, Ghayas C; Kebriaei, Partow; Kornblau, Steven M; Pelletier, Sarah; Flores, Wilmer; Matthews, Jairo; Garris, Rebecca; Kantarjian, Hagop

Short, Nicholas J; Jabbour, Elias; Macaron, Walid; Ravandi, Farhad; Jain, Nitin; Kanagal-Shamanna, Rashmi; Patel, Keyur P; Loghavi, Sanam; Haddad, Fadi G; Yilmaz, Musa; Issa, Ghayas C; Kebriaei, Partow; Kornblau, Steven M; Pelletier, Sarah; Flores, Wilmer; Matthews, Jairo; Garris, Rebecca; Kantarjian, Hagop.

Afiliação

Short NJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Macaron W; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Jain N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Kanagal-Shamanna R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Patel KP; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Loghavi S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Haddad FG; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Yilmaz M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Issa GC; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Kebriaei P; Department of Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Kornblau SM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Pelletier S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Flores W; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Matthews J; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Garris R; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Am J Hematol ; 98(8): 1196-1203, 2023 08.

Article em En | MEDLINE | ID: mdl-37183966

Assuntos

Proteínas de Fusão bcr-abl; Leucemia-Linfoma Linfoblástico de Células Precursoras; Humanos; Proteínas de Fusão bcr-abl/genética; Prognóstico; Reação em Cadeia da Polimerase Via Transcriptase Reversa; Leucemia-Linfoma Linfoblástico de Células Precursoras/diagnóstico; Leucemia-Linfoma Linfoblástico de Células Precursoras/genética; Leucemia-Linfoma Linfoblástico de Células Precursoras/tratamento farmacológico; Neoplasia Residual/diagnóstico; Neoplasia Residual/genética; Sequenciamento de Nucleotídeos em Larga Escala; Recidiva

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas de Fusão bcr-abl / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Am J Hematol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google